Evidence map›Paper›PMID 23417297›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Shigella impairs T lymphocyte dynamics in vivo.

Wilmara Salgado-Pabón, Susanna Celli, Ellen T Arena, Katharina Nothelfer, Pascal Roux, Gernot Sellge, Elisabetta Frigimelica, Philippe Bousso, Philippe J Sansonetti, Armelle Phalipon

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Multifunctional antibody responses from a primateScience translational medicine · 2026
    Article
  2. Article
  3. Shigellosis.Lancet (London, England) · 2025
    Review
  4. Article
  5. Review
  6. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.Frontiers in cellular and infection microbiology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Microbiology spectrum · 2019
    Review
  13. Regulated DelayedTheranostics · 2019
    Article
  14. Human vaccines & immunotherapeutics · 2019
    Review
  15. Recent insights into Shigella.Current opinion in infectious diseases · 2018
    Review
  16. Review
  17. Article
  18. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  19. Article
  20. How Do the Virulence Factors ofFrontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Wilmara Salgado-PabónMolecular Microbial Pathogenesis Unit, Department Cell Biology and Infection, Institut National de Santé et de Recherche Médicale U786, 75724 Paris Cedex 15, France.
Susanna Celli
Ellen T Arena
Katharina Nothelfer
Pascal Roux
Gernot Sellge
Elisabetta Frigimelica
Philippe Bousso
Philippe J Sansonetti
Armelle Phalipon
Biology of Infection · FRInserm · FRInstitut National de Recherche en Santé Publique · MLInstitut Pasteur · FRDynamic Imaging (United Kingdom) · GB

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

The Gram-negative enteroinvasive bacterium Shigella flexneri is responsible for the endemic form of bacillary dysentery, an acute rectocolitis in humans. S. flexneri uses a type III secretion system to inject effector proteins into host cells, thus diverting cellular functions to its own benefit. Protective immunity to reinfection requires several rounds of infection to be elicited and is short-lasting, suggesting that S. flexneri interferes with the priming of specific immunity. Considering the key role played by T-lymphocyte trafficking in priming of adaptive immunity, we investigated the impact of S. flexneri on T-cell dynamics in vivo. By using two-photon microscopy to visualize bacterium-T-cell cross-talks in the lymph nodes, where the adaptive immunity is initiated, we provide evidence that S. flexneri, via its type III secretion system, impairs the migration pattern of CD4(+) T cells independently of cognate recognition of bacterial antigens. We show that bacterial invasion of CD4(+) T lymphocytes occurs in vivo, and results in cell migration arrest. In the absence of invasion, CD4(+) T-cell migration parameters are also dramatically altered. Signals resulting from S. flexneri interactions with subcapsular sinus macrophages and dendritic cells, and recruitment of polymorphonuclear cells are likely to contribute to this phenomenon. These findings indicate that S. flexneri targets T lymphocytes in vivo and highlight the role of type III effector secretion in modulating host adaptive immune responses.

Indexed as

Adaptive ImmunityAnimalsAntigens, BacterialCD4-Positive T-LymphocytesCell MovementDysentery, BacillaryFemaleHost-Pathogen InteractionsMiceMice, KnockoutShigella flexneriSignal TransductionAntigens, Bacterial

Identifiers

PMID23417297
PMCPMC3606969
OpenAlexW1982110424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.